Antonia Busse

8PUBLICATIONS
93CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 27, 2026
CD19 CAR T cell therapy for treatment-refractory seropositive rheumatoid arthritis: a phase 1 trial.

|Jul 29, 2026
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses.

|Jun 12, 2026
Outcomes of CAR T-cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Oct 20, 2025
Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

M Korenkov, J Liebaert, S Yousefian

|Oct 16, 2025
A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies.

Simone Rhein, Neşe Çakmak-Görür, Corinna Grunert

|Feb 11, 2023
Target Selection for T-Cell Therapy in Epithelial Ovarian Cancer: Systematic Prioritization of Self-Antigens.

Paul Schossig, Ebru Coskun, Ruza Arsenic

Pageof 2

Frequent Collaborators

7 joint publications

Ulrich Keller

2 joint publications

Julian Liebaert

2 joint publications

Schayan Yousefian

2 joint publications

Uta Margareta Demel